Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record.

Hot Topics in Pharmacogenetics of Age-Related Macular Degeneration

Grzybowski, Andrzej, Kovach, Jaclyn, Brantley, Milam, Schwartz, Stephen · 2017 · Current Pharmaceutical Design

Abstract

Age-related macular degeneration (AMD) is a leading cause of irreversible visual loss and is primarily treated with nutritional supplementation as well as with anti-vascular endothelial growth factor (VEGF) agents for certain patients with neovascular disease. AMD is a complex disease with both genetic and environmental risk factors. In addition, treatment outcomes from nutritional supplementation and anti-VEGF agents vary considerably. Therefore, it is reasonable to suspect that there may be pharmacogenetic influences on these treatments. Many series have reported individual associations with variants in complement factor H (CFH), age-related maculopathy susceptibility 2 (ARMS2), and other loci. However, at this time there are no validated associations. With respect to AMD, pharmacogenetics remains an intriguing area of research but is not helpful for routine clinical management. Keywords: Age-related macular degeneration (AMD), age-related maculopathy susceptibility 2 (ARMS2), age-related eye disease study (AREDS), complement factor H (CFH), pharmacogenetics, vascular endothelial growth factor (VEGF).

Overview

Integrity signals

Registry

Crossref · 10.2174/1381612822666161208114847

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 4

Metadata

Authors
Grzybowski, A., Kovach, J., Brantley, M., & Schwartz, S.
Affiliations
  • University of Warmia and Mazury in Olsztyn (PL)
  • University of Miami (US)
  • Vanderbilt University (US)
Venue
Current Pharmaceutical Design
Published
2017-03-02
Volume
23
Issue
4
Pages
547-550
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2590186815
Cited by
4
References
0
Citations by year
2024: 1 · 2020: 2 · 2017: 1
FWCI
0.80
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Eye Institute (P30EY014801)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
Keywords
age-related macular degeneration, pharmacogenetics, complement factor H, ARMS2, AREDS, anti-VEGF therapy, dietary supplementation, neovascular AMD, genetic susceptibility loci, treatment response variability
MeSH terms
Age Factors, Humans, Macular Degeneration, Pharmacogenetics, Dietary Supplements, Angiogenesis Inhibitors, Vascular Endothelial Growth Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hot Topics in Pharmacogenetics of Age-Related Macular Degeneration. https://app.cochat.ai/papers/10.2174/1381612822666161208114847
The paper
Grzybowski, A., Kovach, J., Brantley, M., & Schwartz, S. (2017). Hot Topics in Pharmacogenetics of Age-Related Macular Degeneration. Current Pharmaceutical Design. https://doi.org/10.2174/1381612822666161208114847

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.